Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Neurologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Alcohol-related peripheral neuropathy: nutritional, toxic, or both?.Muscle Nerve. 2011; 43: 309-316
- Key substance use and mental health indicators in the United States: results from the 2018 national Survey on drug use and health (HHS publication No. PEP19-5068, NSDUH Series H-54).Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD2019 (Available at:)
- Experimental model of alcohol-related peripheral neuropathy.Muscle Nerve. 2013; 48: 204-211
- Peripheral neuropathy in arsenic smelter workers.Neurology. 1979; 29: 939-944
- Epidemiology of peripheral neuropathy: an Indian perspective.Ann Indian Acad Neurol. 2017; 20: 173-184
- Arsenic toxicity from homeopathic treatment.J Toxicol Clin Toxicol. 2003; 41: 963-967
- Acute demyelinating polyneuropathy with arsenic ingestion.Muscle Nerve. 1996; 19: 1611-1613
- Hair and nails in arsenical neuropathy.Ann Neurol. 1988; 23: 628-629
- Recommendations for medical management of adult lead exposure.Environ Health Perspect. 2007; 115: 463-471
- Lead, mercury, and arsenic poisoning due to topical use of traditional Chinese medicines.Am J Med. 2013; 126: 451-454
- Clinical description of toxic neuropathies.Handb Clin Neurol. 2015; 131: 253-296
- Low-level mercury exposure and peripheral nerve function.Neurotoxicology. 2012; 33: 299-306
- Clinical manifestations and management of acute thallium poisoning.Eur Neurol. 2008; 60: 292-297
- Comparative efficacy of thallium adsorption by activated charcoal, prussian blue, and sodium polystyrene sulfonate.J Toxicol Clin Toxicol. 1999; 37: 833-837
- Occupational neurotoxic diseases in taiwan.Saf Health Work. 2012; 3: 257-267
- The morphology of carbon disulfide neurotoxicity.Neurotoxicology. 1985; 6: 89-96
- Polyneuropathy induced by n-hexane intoxication in Taiwan.Acta Neurol Taiwan. 2008; 17: 3-10
- Focal conduction block in n-hexane polyneuropathy.Muscle Nerve. 1998; 21: 964-969
- N-hexane induced polyneuropathy: a clinical and electrophysiological follow up.Electromyogr Clin Neurophysiol. 2008; 48: 103-108
- 2012 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report.Clin Toxicol (Phila). 2013; 51: 949-1229
- Novichok agents: a historical, current, and toxicological perspective.Toxicol Commun. 2018; 2: 45-48
- A decade after the Tokyo sarin attack: a review of neurological follow-up of the victims.Mil Med. 2007; 172: 607-610
- Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome.N Engl J Med. 1987; 316: 761-763
- Whippits, nitrous oxide and the dangers of legal highs.Pract Neurol. 2015; 15: 207-209
- Peripheral neuropathy associated with fluoroquinolones.Lancet. 1992; 340: 127
- Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.Neurology. 2014; 83: 1261-1263
- Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy.JAMA Neurol. 2019; 76: 827-833
- On the association between fluoroquinolones and neuropathy.JAMA Neurol. 2019; 76: 753-754
- Biologic effects of nitrous oxide: a mechanistic and toxicologic review.Anesthesiology. 2008; 109: 707-722
- Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess.J Clin Neuromuscul Dis. 2014; 16: 25-31
- Vitamin B-6: a status report.J Nutr. 1990; 120 (Suppl 11(4)): 1503-1507
- Chemotherapy-induced peripheral neuropathy: A current review.Ann Neurol. 2017; 81: 772-781
- Lymphoma-associated dysimmune polyneuropathies.J Neurol Sci. 2015; 355: 25-36
- Clinicopathological features of neuropathy associated with lymphoma.Brain. 2013; 136: 2563-2578
- Neurological complications in plasma cell dyscrasias.Handb Clin Neurol. 2012; 105: 731-746
- Amyloid neuropathies.Mt Sinai J Med. 2012; 79: 733-748
- Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.J Clin Oncol. 2014; 32: 1941-1967
- Characterization of internal validity threats to phase III clinical trials for chemotherapy-induced peripheral neuropathy management: a systematic review.Asia Pac J Oncol Nurs. 2019; 6: 318-332
- Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.Support Care Cancer. 2019; 28: 1183-1197
- Analysis of side effect profile of alopecia, nail changes, peripheral neuropathy, and dysgeusia in prostate cancer patients treated with docetaxel and cabazitaxel.Clin Genitourin Cancer. 2015; 13: e205-e208
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.Cancer. 2012; 118: 5171-5178
- Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.J Peripher Nerv Syst. 2015; 20: 37-46
- Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy.J Cancer Res Ther. 2015; 11: 666
- Vincristine neurotoxicity.Ann Intern Med. 1974; 80: 733-737
- Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach.Clin Breast Cancer. 2011; 11: 73-81
- Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation.Blood. 2012; 120: 560-568
- Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer.Breast Cancer Res. 2016; 18: 34
- Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.J Clin Invest. 1998; 101: 2842-2850
- Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.J Neurol Sci. 2015; 349: 124-128
- Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.Muscle Nerve. 2004; 29: 387-392
- Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.Haematologica. 2015; 100: e207-e210
- A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment.Muscle Nerve. 2012; 46: 970-977
- The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma.Ann Oncol. 2002; 13: 1636-1640
- Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective study.Neurology. 2016; 87: 1161-1166
- Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.Leuk Lymphoma. 2016; 57: 2833-2838
Article info
Publication history
Published online: September 12, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
